Anxiety, Covid19, Depression
Conditions
Keywords
COVID19, Anxiety, Depression
Brief summary
The covid-19 pandemic started to spread worldwide since December 2019. It promoted to an exaggerated psychological stress and anxiety in humans due to the intolerable symptoms higher than usual death of many infected patients. This study examines the corona related anxiety and if there is need for drug intervention to treat this anxiety. To answer these questions, a survey made to the hospitalized patients including sex, age, educational level, Marital state, and a standardized questionnaires (GAD-7 and PHQ-9) which has been validated and shown to possess good psychometric qualities in studies of participants from multiple populations.
Interventions
None listed
Sponsors
University of Basrah
Ministry of Health, Iraq
Alhasan Mujtaba Al-Mudhaffer
Study design
Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
15 Years to No maximum
Healthy volunteers
No
Inclusion criteria
\- patients with COVID19 willing to participate in the study
Exclusion criteria
* unwilling unable to read or interact with standardized questionnaire unconscious
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| depression | at the time of acute infection, average of 1 month | Depression measured by Patient Health Questionnaire-9 (PHQ-9) scale. Scoring: 5-9 mild;10-14 moderate; 15-19 moderately severe; \>20 severe. Minimum 0 maximum 27 points |
| anxiety | at the time of acute infection, average of 1 month | Anxiety measured by General Anxiety Disorder-7 (GAD-7) scale. Scoring:5-9 mild; 10-14 moderate; \>15 severe. Minimum 0, maximum 21 points |
Countries
Iraq
Outcome results
None listed